AI Analysis

How does AREVF make money? Does AREVF have pricing power? What's the Earnings Whisper? Will AREVF profit more as the business scales? What is AREVF's management track record? Is AREVF's current price justified?

AREV Life Sciences Global Corp

$0 -$0.00 (-0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.01

Year Range

$0$0.01

Market Cap

15.88K

AVG Volume

9.33K

Trailing/Forward PE

-1.87/-

PEG ratio

-0.03

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD) · TTM

AREVF Revenue (CAD) · TTM by quarter
Period	Revenue (CAD) · TTM
23 Q3	7.21K
23 Q2	30.3K
23 Q1	40.49K
22 Q4	49.11K
22 Q3	183.89K
22 Q2	187.28K
22 Q1	220.28K
21 Q4	254.25K
21 Q3	166.12K
21 Q2	188.53K

Net Income (CAD) · TTM

AREVF Net Income (CAD) · TTM by quarter
Period	Net Income (CAD) · TTM
23 Q3	-239.54K
23 Q2	-451.27K
23 Q1	-1.1M
22 Q4	-1.44M
22 Q3	-1.02M
22 Q2	-1M
22 Q1	-923.65K
21 Q4	-980.02K
21 Q3	-1.98M
21 Q2	-1.92M

Operating Income (CAD) · TTM

AREVF Operating Income (CAD) · TTM by quarter
Period	Operating Income (CAD) · TTM
23 Q3	-194.43K
23 Q2	-402.26K
23 Q1	-1.05M
22 Q4	-1.39M
22 Q3	-1.72M
22 Q2	-1.7M
22 Q1	-1.61M
21 Q4	-1.66M
21 Q3	-1.92M
21 Q2	-1.86M

EBITDA (CAD) · TTM

AREVF EBITDA (CAD) · TTM by quarter
Period	EBITDA (CAD) · TTM
23 Q3	-165.22K
23 Q2	-339.85K
23 Q1	-971.71K
22 Q4	-1.29M
22 Q3	-857.51K
22 Q2	-840.51K
22 Q1	-748.7K
21 Q4	-787.34K
21 Q3	-1.78M
21 Q2	-1.71M

Cash Flows (CAD) · TTM

AREVF Cash Flows (CAD) · TTM by quarter
Period	Cash Flows (CAD) · TTM
23 Q3	-153.36K
23 Q2	-152.85K
23 Q1	-204.22K
22 Q4	-366.2K
22 Q3	-415.81K
22 Q2	-472K
22 Q1	-1.18M
21 Q4	-1.48M
21 Q3	-1.48M
21 Q2	-1.44M

EPS (CAD) · TTM

AREVF EPS (CAD) · TTM by quarter
Period	EPS (CAD) · TTM
23 Q3	-0.01
23 Q2	-0.01
23 Q1	-0.04
22 Q4	-0.05
22 Q3	-0.03
22 Q2	-0.03
22 Q1	-0.04
21 Q4	-0.04
21 Q3	-0.09
21 Q2	-0.09

Expenses (CAD) · TTM

AREVF Expenses (CAD) · TTM by quarter
Period	Expenses (CAD) · TTM
23 Q3	108.26K
23 Q2	334.2K
23 Q1	1.02M
22 Q4	1.39M
22 Q3	1.81M
22 Q2	1.79M
22 Q1	1.73M
21 Q4	1.78M
21 Q3	1.96M
21 Q2	1.91M

Shares Outstanding · TTM

AREVF Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
23 Q3	169.74K
23 Q2	156.1K
23 Q1	-130.84K
22 Q4	-144.19K
22 Q3	-514.17K
22 Q2	-500.53K
22 Q1	-455.93K
21 Q4	-455.41K
21 Q3	-438.3K
21 Q2	-438.3K

Free Cash Flow Yield

AREVF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-695.8%
Sep 26	-697.67%
Aug 26	-694.17%
Aug 26	-701.14%
Aug 26	-695.62%
Aug 26	-692.46%
Jul 26	-688.7%
Jul 26	-684.79%
Jul 26	-688.32%
Jul 26	-681.95%
Jul 26	-680.49%
Jun 26	-680.17%
Jun 26	-682.61%
Jun 26	-689.9%
Jun 26	-692.38%
May 26	-699.94%
May 26	-698.52%
May 26	-702.09%
May 26	-705.7%
May 26	-710.32%
Apr 26	-706.17%
Apr 26	-704.96%
Apr 26	-697.31%
Apr 26	-693.36%
Mar 26	-694.74%
Mar 26	-703.43%
Mar 26	-703.34%
Mar 26	-711.69%
Feb 26	-707.6%
Feb 26	-705.76%
Feb 26	-708.85%
Feb 26	-705.93%
Jan 26	-708.74%
Jan 26	-704.55%
Jan 26	-693.57%
Jan 26	-693.74%
Jan 26	-702.97%
Dec 25	-705.88%
Dec 25	-699.47%
Dec 25	-700.81%
Dec 25	-698.55%
Nov 25	-34.54%
Nov 25	-34.23%
Nov 25	-34.42%
Nov 25	-34.35%
Oct 25	-34.46%
Oct 25	-34.48%
Oct 25	-34.42%
Oct 25	-34.47%
Oct 25	-34.6%
Sep 25	-34.62%
Sep 25	-35.04%
Sep 25	-34.85%
Sep 25	-34.9%
Aug 25	-35.12%
Aug 25	-34.91%
Aug 25	-34.93%
Aug 25	-35.08%
Aug 25	-35%
Jul 25	-35.23%
Jul 25	-35.17%
Jul 25	-35.26%
Jul 25	-35.53%
Jun 25	-35.28%
Jun 25	-35.14%
Jun 25	-35.54%
Jun 25	-35.25%
May 25	-35.13%
May 25	-35.15%
May 25	-34.55%
May 25	-34.64%
May 25	-34.93%
Apr 25	-34.84%
Apr 25	-34.88%
Apr 25	-34.81%
Apr 25	-33.92%
Mar 25	-33.71%
Mar 25	-33.63%
Mar 25	-33.58%
Mar 25	-33.6%
Feb 25	-33.37%
Feb 25	-33.94%
Feb 25	-34.03%
Feb 25	-33.78%
Jan 25	-33.23%
Jan 25	-33.65%
Jan 25	-33.33%
Jan 25	-33.47%
Jan 25	-33.41%
Dec 24	-33.49%
Dec 24	-33.58%
Dec 24	-33.91%
Dec 24	-34.1%
Nov 24	-34.47%
Nov 24	-34.54%
Nov 24	-34.26%
Nov 24	-34.7%
Nov 24	-34.6%
Oct 24	-34.74%
Oct 24	-34.97%

Price to Sales

AREVF Price to Sales by quarter
Period	Price to Sales
Sep 26	3.06
Sep 26	3.05
Aug 26	3.06
Aug 26	3.03
Aug 26	3.06
Aug 26	3.07
Jul 26	3.09
Jul 26	3.11
Jul 26	3.09
Jul 26	3.12
Jul 26	3.13
Jun 26	3.13
Jun 26	3.12
Jun 26	3.08
Jun 26	3.07
May 26	3.04
May 26	3.05
May 26	3.03
May 26	3.01
May 26	2.99
Apr 26	3.01
Apr 26	3.02
Apr 26	3.05
Apr 26	3.07
Mar 26	3.06
Mar 26	3.02
Mar 26	3.02
Mar 26	2.99
Feb 26	3.01
Feb 26	3.01
Feb 26	3
Feb 26	3.01
Jan 26	3
Jan 26	3.02
Jan 26	3.07
Jan 26	3.07
Jan 26	3.03
Dec 25	3.01
Dec 25	3.04
Dec 25	3.04
Dec 25	3.05
Nov 25	61.6
Nov 25	62.15
Nov 25	61.81
Nov 25	61.93
Oct 25	61.73
Oct 25	61.7
Oct 25	61.8
Oct 25	61.71
Oct 25	61.48
Sep 25	61.45
Sep 25	60.72
Sep 25	61.04
Sep 25	60.95
Aug 25	60.57
Aug 25	60.93
Aug 25	60.91
Aug 25	60.64
Aug 25	60.79
Jul 25	60.39
Jul 25	60.49
Jul 25	60.34
Jul 25	59.88
Jun 25	60.3
Jun 25	60.55
Jun 25	59.87
Jun 25	60.35
May 25	60.56
May 25	60.52
May 25	61.57
May 25	61.42
May 25	60.9
Apr 25	61.06
Apr 25	60.99
Apr 25	61.12
Apr 25	62.72
Mar 25	63.1
Mar 25	63.27
Mar 25	63.35
Mar 25	63.32
Feb 25	63.75
Feb 25	62.67
Feb 25	62.52
Feb 25	62.98
Jan 25	64.03
Jan 25	63.22
Jan 25	63.83
Jan 25	63.56
Jan 25	63.68
Dec 24	63.53
Dec 24	63.35
Dec 24	62.73
Dec 24	62.39
Nov 24	61.72
Nov 24	61.6
Nov 24	62.09
Nov 24	61.3
Nov 24	61.48
Oct 24	61.23
Oct 24	60.83

Price/Operating Cashflow

AREVF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 20	23.14
Sep 20	22.82
Sep 20	22.77
Sep 20	22.58
Aug 20	22.54
Aug 20	92.72
Aug 20	93.38
Aug 20	94.18
Jul 20	94.39
Jul 20	94.42
Jul 20	95.59
Jul 20	96.23
Jul 20	96.03

Price to Book

AREVF Price to Book by quarter
Period	Price to Book
Mar 20	0.94
Mar 20	0.96
Mar 20	0.93
Mar 20	2.4
Feb 20	3.39
Feb 20	2.37
Feb 20	2.37
Feb 20	2.71
Jan 20	2.7
Jan 20	2.68
Jan 20	1.64
Jan 20	4.03
Jan 20	4.01

No video analysis for this stock yet. Request one from our team.

AI Analysis

AREV Life Sciences Global Corp

Video analysis: AREVF

Similar companies